RESUMO
BACKGROUND: The Finnish Diabetes Risk Score (FINDRISC) questionnaire has been used to assess the risk of type 2 diabetes and metabolic syndrome. The objetive was to assess the relationship between different scales related to cardiovascular risk and FINDRISC questionnaire. METHODS: Values of different anthropometric and clinical parameters (body mass index, waist circumference, waist to height ratio, blood pressure), analytical parameters (lipid profile, blood glucose) and scales related to cardiovascular risk (atherogenic index, metabolic syndrome, REGICOR, SCORE, heart age and vascular age) were determined on the basis of the value of the FINDRISC questionnaire. RESULTS: All analyzed parameters related to cardiovascular risk were getting worse at the same time that the value of the FINDRISC questionnaire increased. CONCLUSIONS: There is a close relationship between FINDRISC questionnaire values and those obtained in the different parameters by which cardiovascular risk was measured directly or indirectly.
Introducción: el Finnish Diabetes Risk Score (test de FINDRISC) se ha empleado para valorar el riesgo de padecer diabetes tipo 2 y síndrome metabólico. El objetivo consistió en valorar la relación entre diferentes escalas relacionadas con el riesgo cardiovascular y el test de FINDRISC. Métodos: se determinaron los valores de difentes parámetros antropométricos, clínicos (índice de masa corporal, perímetro de cintura, índice cintura altura, tensión arterial), analíticos (perfil lipídico y glucemia) y escalas relacionadas con riesgo cardiovascular (indices aterogénicos, síndrome metabólico, REGICOR, SCORE, edad del corazón y edad vascular) según el valor del test de FINDRISC. Resultados: todos los parámetros relacionados con riesgo cardiovascular analizados fueron empeorando a medida que aumentaba el valor del test de FINDRISC. Conclusión: existe una estrecha relación entre los valores del test de FINDRISC y los obtenidos en los diferentes parámetros y escalas que valoran de forma directa o indirecta el riesgo cardiovascular.
Assuntos
Doenças Cardiovasculares/diagnóstico , Diabetes Mellitus Tipo 2/diagnóstico , Indicadores Básicos de Saúde , Adulto , Doenças Cardiovasculares/etiologia , Estudos Transversais , Diabetes Mellitus Tipo 2/etiologia , Feminino , Humanos , Masculino , Região do Mediterrâneo , Pessoa de Meia-Idade , Medição de Risco , Fatores de Risco , EspanhaRESUMO
INTRODUCTION: The impaired fasting glucose (IFG) is an intermediate clinical situation between normal glucose and type 2 diabetes, it is known that 25% of people with IFG progress to type 2 diabetes. METHODS: Descriptive study in 60,798 Spanish workers. The IFG was determined using the American Diabetes Association (ADA) criteria: 100-125 mg/dl and the World Health Organization (WHO) criteria: 110-125 mg/dl. The influence of sociodemographic variables (age, sex, social class, studies class) and healthy habits (tobacco, alcohol consumption, physical activity, feeding) were evaluated in the IFG prevalence. RESULTS: The IFG prevalence was 3.3% (1.8% in women and 4.5% in men) using the WHO criteria and 11.8% (7% in women and 15.4% in men) using the ADA criteria. The IFG is more common in men and increases with age. People with low socioeconomic status (social classes IV and V, blue collar and primary studies) and poor health habits (smokers, heavy alcohol consumption and low physical activity) have a higher prevalence. CONCLUSIONS: The sociodemographic variables and the healthy habits, except consumption of fruits and vegetables, influence the prevalence of IFG.